Homocysteine Induces Programmed Cell Death in Human Vascular Endothelial Cells through Activation of the Unfolded Protein Response*

Severe hyperhomocysteinemia is associated with endothelial cell injury that may contribute to an increased incidence of thromboembolic disease. In this study, homocysteine induced programmed cell death in human umbilical vein endothelial cells as measured by TdT-mediated dUTP nick end labeling assay, DNA ladder formation, induction of caspase 3-like activity, and cleavage of procaspase 3. Homocysteine-induced cell death was specific to homocysteine, was not mediated by oxidative stress, and was mimicked by inducers of the unfolded protein response (UPR), a signal transduction pathway activated by the accumulation of unfolded proteins in the lumen of the endoplasmic reticulum. Dominant negative forms of the endoplasmic reticulum-resident protein kinases IRE1α and -β, which function as signal transducers of the UPR, prevented the activation of glucose-regulated protein 78/immunoglobulin chain-binding protein and C/EBP homologous protein/growth arrest and DNA damage-inducible protein 153 in response to homocysteine. Furthermore, overexpression of the point mutants of IRE1 with defective RNase more effectively suppressed the cell death than the kinase-defective mutant. These results indicate that homocysteine induces apoptosis in human umbilical vein endothelial cells by activation of the UPR and is signaled through IRE1. The studies implicate that the UPR may cause endothelial cell injury associated with severe hyperhomocysteinemia.

[1]  Charles R.scriver,et al.  The Metabolic basis of inherited disease , 1989 .

[2]  J. Sadler,et al.  Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum. , 1993, Blood.

[3]  D. Ron,et al.  Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase , 1999, Nature.

[4]  G. Rodgers,et al.  Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. , 1986, The Journal of clinical investigation.

[5]  K. Shimada,et al.  Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. , 1993, The Journal of clinical investigation.

[6]  T. Aso,et al.  Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells: activation of c-Jun NH(2)-terminal kinase and promoter response element. , 2000, Blood.

[7]  Masahiko Kuroda,et al.  Cloning of mammalian Ire1 reveals diversity in the ER stress responses , 1998, The EMBO journal.

[8]  G. Rodgers,et al.  Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[9]  R. Green,et al.  Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease. , 1999, Advances in enzyme regulation.

[10]  L. Solomon,et al.  The Metabolic Basis of Inherited Disease , 1979 .

[11]  Amy S. Lee,et al.  Generation of a Mammalian Cell Line Deficient in Glucose-regulated Protein Stress Induction through Targeted Ribozyme Driven by a Stress-inducible Promoter (*) , 1995, The Journal of Biological Chemistry.

[12]  R. Kaufman,et al.  A stress response pathway from the endoplasmic reticulum to the nucleus requires a novel bifunctional protein kinase/endoribonuclease (Ire1p) in mammalian cells. , 1998, Genes & development.

[13]  J. Hirsh,et al.  Characterization of the stress-inducing effects of homocysteine. , 1998, The Biochemical journal.

[14]  F. Urano,et al.  Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. , 2000, Science.

[15]  G. Rodgers,et al.  Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. , 1990, Blood.

[16]  J. Sadler,et al.  Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. , 1991, The Journal of clinical investigation.

[17]  G. Boers,et al.  Endothelial cell dysfunction in homocystinuria , 1983, European journal of clinical investigation.

[18]  L. Philipson,et al.  CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. , 1994, Genes & development.

[19]  R. Kaufman,et al.  The endoribonuclease activity of mammalian IRE1 autoregulates its mRNA and is required for the unfolded protein response. , 2000, Genes & development.

[20]  R. Ross,et al.  Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons. , 1983, Circulation research.

[21]  K. Hajjar Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. , 1993, The Journal of clinical investigation.

[22]  J. Loscalzo,et al.  Homocysteine and atherothrombosis. , 1998, The New England journal of medicine.

[23]  K. Mccully Homocysteine and vascular disease , 1996, Nature Medicine.

[24]  R. Schlegel,et al.  Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Chait,et al.  The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. , 1987, The Journal of biological chemistry.

[26]  R. Kaufman,et al.  Immunoglobulin Binding Protein (BiP) Function Is Required to Protect Cells from Endoplasmic Reticulum Stress but Is Not Required for the Secretion of Selective Proteins* , 1997, The Journal of Biological Chemistry.

[27]  Xiaozhong Wang,et al.  CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. , 1998, Genes & development.

[28]  J. Sambrook,et al.  The cellular response to unfolded proteins: intercompartmental signaling. , 1994, Current opinion in biotechnology.

[29]  Hong Liu,et al.  Endoplasmic Reticulum Chaperones GRP78 and Calreticulin Prevent Oxidative Stress, Ca2+ Disturbances, and Cell Death in Renal Epithelial Cells* , 1997, The Journal of Biological Chemistry.

[30]  G. Singh,et al.  Homocysteine-dependent Alterations in Mitochondrial Gene Expression, Function and Structure , 1998, The Journal of Biological Chemistry.

[31]  Shizuo Akira,et al.  Ectopic expression of CHOP (GADD153) induces apoptosis in M1 myeloblastic leukemia cells , 1996, FEBS letters.

[32]  M. Peterson,et al.  Induction of Endothelial Cell Apoptosis by TNFα: Modulation by Inhibitors of Protein Synthesis , 1994 .

[33]  T. Miyata,et al.  Homocysteine-respondent Genes in Vascular Endothelial Cells Identified by Differential Display Analysis , 1996, The Journal of Biological Chemistry.

[34]  T. Tan,et al.  Persistent Activation of c-Jun N-terminal Kinase 1 (JNK1) in γ Radiation-induced Apoptosis (*) , 1996, The Journal of Biological Chemistry.

[35]  Yan-Lin Guo,et al.  Correlation between Sustained c-Jun N-terminal Protein Kinase Activation and Apoptosis Induced by Tumor Necrosis Factor-α in Rat Mesangial Cells* , 1998, The Journal of Biological Chemistry.

[36]  R. Kaufman,et al.  Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. , 1999, Genes & development.

[37]  E. Haber,et al.  Inhibition of Growth and p21 ras Methylation in Vascular Endothelial Cells by Homocysteine but Not Cysteine* , 1997, The Journal of Biological Chemistry.

[38]  A. Nègre-Salvayre,et al.  Oxidized LDLs induce massive apoptosis of cultured human endothelial cells through a calcium-dependent pathway. Prevention by aurintricarboxylic acid. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[39]  G. Starkebaum,et al.  Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. , 1986, The Journal of clinical investigation.

[40]  T. Podor,et al.  Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. , 1999, Blood.

[41]  K. Agarwala,et al.  Analysis of Gene Expression in Homocysteine-Injured Vascular Endothelial Cells: Demonstration of GRP78/BiP Expression, Cloning and Characterization of a Novel Reducing Agent-Tunicamycin Regulated Gene , 1998, Seminars in thrombosis and hemostasis.

[42]  M. Mirault,et al.  Differential expression of hsp70 stress proteins in human endothelial cells exposed to heat shock and hydrogen peroxide. , 1991, American journal of respiratory cell and molecular biology.

[43]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[44]  J. Hladovec,et al.  Homocysteinemia and endothelial damage after methionine load. , 1997, Thrombosis research.

[45]  Y. Itoyama,et al.  Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response , 1999, Nature Cell Biology.

[46]  D. Ron,et al.  CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. , 1992, Genes & development.

[47]  A. Karsan,et al.  Endothelial Cell Death Induced by Tumor Necrosis Factor-α Is Inhibited by the Bcl-2 Family Member, A1* , 1996, The Journal of Biological Chemistry.

[48]  J. Loscalzo,et al.  Homocyst(e)ine Decreases Bioavailable Nitric Oxide by a Mechanism Involving Glutathione Peroxidase* , 1997, The Journal of Biological Chemistry.

[49]  A. Zeiher,et al.  Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis. , 1997, Circulation.